Unknown

Dataset Information

0

Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.


ABSTRACT: Malignant gliomas derive from brain glial cells and represent >75% of primary brain tumors. This includes anaplastic astrocytoma (grade III; AS), the most common and fatal glioblastoma multiforme (grade IV; GBM), and oligodendroglioma (ODG). We have generated patient-derived AS, GBM, and ODG cell models to study disease mechanisms and test patient-centered therapeutic strategies. We have used an aptamer-based high-throughput SOMAscan® 1.3K assay to determine the proteomic profiles of 1307 different analytes. SOMAscan® proteomes of AS and GBM self-organized into closely adjacent proteomes which were clearly distinct from ODG proteomes. GBM self-organized into four proteomic clusters of which SOMAscan® cluster 4 proteome predicted a highly inter-connected proteomic network. Several up- and down-regulated proteins relevant to glioma were successfully validated in GBM cell isolates across different SOMAscan® clusters and in corresponding GBM tissues. Slow off-rate modified aptamer proteomics is an attractive analytical tool for rapid proteomic stratification of different malignant gliomas and identified cluster-specific SOMAscan® signatures and functionalities in patient GBM cells.

SUBMITTER: Thanasupawat T 

PROVIDER: S-EPMC8431317 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3349859 | biostudies-literature
| S-EPMC5625393 | biostudies-literature
| S-EPMC8657496 | biostudies-literature
| S-EPMC7236427 | biostudies-literature
| S-EPMC6316431 | biostudies-literature
| S-EPMC6253716 | biostudies-literature
| S-EPMC5256960 | biostudies-literature
| S-EPMC4338494 | biostudies-literature
| S-EPMC5828703 | biostudies-literature
| S-EPMC3905890 | biostudies-other